Search Results

Displaying Results 5201-5225 of 10947 "'T'"

Apr 09, 2026, 17:46 ET /C O R R E C T I O N -- TalentNeuron/

More news about: TalentNeuron


Apr 09, 2026, 17:43 ET /C O R R E C T I O N -- Sequel Brands/

More news about: Sequel Brands


Apr 09, 2026, 17:35 ET /C O R R E C T I O N -- Sanrio/

More news about: Sanrio


Apr 09, 2026, 16:30 ET Rowan Digital Infrastructure Announces Strategic Recapitalization

[email protected] T: 971-219-5561QuinbrookRenae McGregor, Head of Marketing and CommunicationsEmail: [email protected]T: +44 7557 386 949BlackstoneClaire

More news about: Rowan Digital Infrastructure


Apr 09, 2026, 16:01 ET Auburn's College of Education rises in U.S. News & World Report's 2026 Best Graduate Schools ranking

year's ranking further reflects our College of Education's strong placement among top peers in the country," said Jeffrey Fairbrother, dean and Wayne T. Smith Distinguished Professor of Auburn's College of Education. "It is a testament to the dedicated efforts of our faculty, staff and students who work

More news about: Auburn University College of Education


Apr 09, 2026, 14:16 ET California Court of Appeal Reverses Suzuki Verdict and Orders New Trial

Forman.Plaintiff's appellate counsel was Benjamin Siminou of Singleton Schreiber; trial counsel were Gabe Houston of Gordon & Partners and Robert T. Simon, Travis Davis and Tom Feher of The Simon Law Group.

More news about: Suzuki Motor USA, LLC


Apr 09, 2026, 14:15 ET The Inner Circle acknowledges Eric Y.T. Yang as a Pinnacle Lifetime Member

Yang is recognized as a Pinnacle Lifetime Member for his contributions to Advancing the Future of Wound Care and Hyperbaric Medicine. Dr. Eric Y. T. Yang has cultivated an exceptional medical career marked by dedication, innovation, and patient-centered care. A former general surgeon who transitioned

More news about: The Inner Circle


Apr 09, 2026, 14:15 ET Rising Complexity Becomes Defining Challenge in Vehicle Logistics, INFORM Study Finds

[email protected] Media ContactValerie Harding Ripple Effect PR Specialist for INFORM T: 617-536-8887 E: [email protected]

More news about: INFORM GmbH


Apr 09, 2026, 14:00 ET InventHelp Inventor Develops New Attachments for a Powered Caulking Gun (TRO-1584)

attachments that would effectively extend the reach of a powered/pneumatic caulking tool," said an inventor, from Milverton, ON, Canada, "so I invented the T D S CAULKING TOOL. My design enables you to safely stand on the floor and apply caulking material to gaps that are 8 to 9 feet above the floor."

More news about: InventHelp


Apr 09, 2026, 13:52 ET /C O R R E C T I O N -- CIQ/

More news about: CIQ


Apr 09, 2026, 13:47 ET Liệu pháp CAR-T đầu tiên trên thế giới cho khối u rắn sắp được triển khai tại Trung Quốc

(CT041), là phương pháp điều trị CAR-T đầu tiên trên thế giới được phát triển đặc hiệu cho khối u rắn nhắm vào Claudin18.2, một dấu ấn sinh học thường gặp trong ung thư dạ dày và ung thư tuyến tụy.Kỷ nguyên mới trong điều trị ung thưLiệu pháp CAR-T là một phương pháp điều trị có tính

More news about: Jiahui Health


Apr 09, 2026, 13:04 ET The Misty Copeland Foundation to Host Spring Benefit Honoring Misty Copeland's Legacy

Co-Chairs for the evening, including legendary choreographer and director Debbie Allen, acclaimed choreographer and artistic director Bill T. Jones, Emmy Award-winning actress Sheryl Lee Ralph, Grammy Award-winning music icon Nile Rodgers, and award-winning actress and producer

More news about: The Misty Copeland Foundation


Apr 09, 2026, 12:55 ET DualityBio anuncia la aceptación de NMPA de China de su solicitud de licencia para productos biológicos

conjuntamente la comercialización de DB-1303/T-Pam para múltiples indicaciones en China continental, Hong Kong y Macao. A nivel global, seguiremos profundizando nuestra alianza estratégica con BioNTech para impulsar aún más el desarrollo mundial de este producto. DB-1303/T-Pam es un fármaco desarrollado conjuntamente

More news about: DualityBio


Apr 09, 2026, 12:52 ET Unrivaled Sports Partners with Under Armour and DICK'S Sporting Goods to Build the Future of Youth Sports Experiences

/C O R R E C T I O N – Unrivaled Sports/ In the news release, Unrivaled Sports Partners with Under Armour and DICK'S Sporting Goods to Build the Future of Youth Sports Experiences, issued 09-Apr-2026 by Unrivaled Sports over PR Newswire, we are advised by the company that changes have been made.

More news about: Unrivaled Sports


Apr 09, 2026, 11:00 ET HEAD Unleashes SQUARED: Power and Comfort in a Game-Changing Racquet

SQUARED's dual-tube architecture separates power from comfort in a single frame. The outer tube, using Torayca™ T800S carbon fiber, optimizes stability and power. The foam-filled Comfort Tube, running from grip to main string bed, absorbs vibration and reduces arm

More news about: HEAD


Apr 09, 2026, 10:55 ET Why Smart Money Is Chasing Polymetallic Deposits Right Now

a 0.50-metre sample grading 82,334 g/t silver containing abundant native silver, representing the highest-grade single sample ever reported by the company and among the highest silver grades ever reported globally. The hole returned 11.35 metres averaging 4,560 g/t silver, with multiple additional bonanza-grade

More news about: USA News Group


Apr 09, 2026, 10:00 ET ENT & Allergy of Delaware Named Castle Connolly's #1 Private Practice for Top Doctors in Delaware for 2026

MDGregory V. Marcotte, MDJonathan Romak, MDIsma Shah, MDWilliam M. Sheppard, MDMichelle M. Squadrito, MDMichael T. Teixido, MDAbout Castle Connolly Top DoctorsCastle Connolly's physician-led research team rigorously evaluates nominees to select

More news about: ENT & Allergy of Delaware


Apr 09, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

treat autoimmune disorders. The Company's lead product candidate is rezpegaldesleukin (a/k/a REZPEG or NKTR-358), a novel, first-in-class regulatory T cell stimulator for the treatment of, inter alia, alopecia areata.          In March 2024, Nektar initiated its Phase 2b REZOLVE-AA trial,

More news about: Pomerantz LLP


Apr 09, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA

diseases in the United States and the United Kingdom. The Company's lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-cell immunotherapy program for the treatment of, inter alia, Epstein-Barr virus positive post-transplant lymphoproliferative disease ("EBV+ PTLD").Atara

More news about: Pomerantz LLP


Apr 09, 2026, 09:49 ET LiveOak Fiber Secures New Funding to Accelerate Fiber Expansion

OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ – GS: TROW). For more information, please visit 

More news about: LiveOak Fiber


Apr 09, 2026, 09:05 ET Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

lira-cel, an ovarian cancer immunotherapy being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. This technology is differentiated from other cell therapies as the natural ligand of the FSHR receptor, FSH,

More news about: Anixa Biosciences, Inc.


Apr 09, 2026, 09:00 ET Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

advanced into the critical Phase III stage of its global development for three proposed indications: obesity/overweight, type 2 diabetes mellitus (T2DM), and obstructive sleep apnea (OSA). Existing clinical data demonstrate that Bofanglutide can effectively reduce body weight and blood glucose levels

More news about: Gan & Lee Pharmaceuticals


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.